Impact of Caffeine on the Blood Stem Cells in Healthy Adults
Official title: CaffeineHSC - Effect of Chronic Caffeine Consumption and Acute Caffeine Administration on the Hematopoietic System
Run by ETH Zurich · NCT07193264 · Data updated 2026-11-12
This study tests whether a single 200 mg dose of caffeine changes blood stem and progenitor cells in healthy adults who regularly drink caffeine compared with those who rarely or never do.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | ETH Zurich Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Zurich, Canton of Zurich and 1 other locations) |
| Status | Recruiting |
| Started | November 5, 2025 |
| Main results expected | December 2027 |
| Study ends | June 2028 |
| Registry record updated | July 6, 2026 |
| Trial ID | NCT07193264 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults aged 18 years and older who regularly consume caffeine or consume very little/none for at least 6 months and can fast for the study.
✕Probably not a fit
People with chronic illnesses, hematologic disorders, or those who cannot fast or have caffeine intolerance are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study administers a single 200 mg caffeine tablet to healthy adult participants under fasting conditions to examine its effects on blood hematopoietic cells. Participants are grouped by regular caffeine consumption versus minimal/no intake and blood samples are collected before and three hours after dosing. Outcomes include changes in mobilization of stem and progenitor cells from bone marrow into the bloodstream, as well as effects on cell function, gene activity, and metabolism. The trial uses a controlled, single-dose design with translational measurements in human subjects to understand caffeine’s immediate hematopoietic effects.
Why it matters
Potential benefit: If successful, findings may clarify how caffeine could influence blood cell biology in healthy individuals.
How similar studies have gone: Previous research in humans has explored caffeine’s systemic effects, but studies directly linking caffeine to hematopoietic cell mobilization and function are limited and largely exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Able to give consent. * Healthy adults aged ≥ 18 years. * Regular caffeine consumers (≥1 coffee cup/day or ≥1 energy drink/day) or non-consumers (≤1 cup/month and ≤1 energy drink/month) for at least 6 months. * Willingness to comply with fasting requirements and study procedures. Exclusion Criteria: * Chronic illnesses or medication use affecting metabolism, including metabolic disorders (e.g., diabetes, thyroid dysfunction, metabolic syndrome). * Personal history of cancer. * Personal history of hematological disorders. * History of radiation therapy. * Known caffeine hypersensitivity or intolerance. * Known immunosuppression.
Where it's running
-
Eth Glc
Zurich, Canton of Zurich, Switzerland Recruiting -
Eth Glc
Zurich, Canton of Zurich, Switzerland Not yet recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Morning-strength boost with caffeine or whole-body vibration
This study tests whether taking 300 mg caffeine or using whole-body vibration helps healthy, regularly trained adults see improvements in morning strength and thinking skills.
-
How external factors affect 2D-NIRS tissue oxygenation measurements in healthy volunteers
This study tests how things like temperature, activity, caffeine, and nicotine influence 2D-NIRS measurements of tissue oxygenation in healthy adults.
-
Does caffeine help professional chess players think faster and play better?
In this study, professional chess players try caffeinated versus decaffeinated coffee to see if caffeine improves focus, reaction time, and game performance.
-
Does Caffeine or Alcohol Change Pupil Reactions? A Test in Healthy Adults
This study tests how caffeine and alcohol affect pupil responses and eye movements, and whether these changes can indicate recent intake, in adults aged 30-50.
-
Sublingual caffeine to shorten recovery and reduce agitation after general anesthesia in older adults
This trial will test whether a single dose of sublingual caffeine helps people aged 65 and older wake up faster and have less postoperative agitation after elective eye surgery under general anesthesia.
-
Effects of caffeine on learning in healthy adults using brain imaging
This study tests how caffeine affects learning and brain activity in healthy adults by comparing its effects to a placebo during tasks that involve rewards.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.